S.M.A.I.O Future Growth
Future criteria checks 1/6
S.M.A.I.O is forecast to grow earnings and revenue by 41.1% and 19.1% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 11.9% in 3 years.
Key information
41.1%
Earnings growth rate
41.0%
EPS growth rate
Medical Equipment earnings growth | 13.8% |
Revenue growth rate | 19.1% |
Future return on equity | 11.9% |
Analyst coverage | Low |
Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 10 | 1 | -2 | 15 | 1 |
12/31/2024 | 5 | -2 | -3 | 13 | 1 |
12/31/2023 | 6 | -1 | -2 | 13 | 1 |
6/30/2023 | 7 | -1 | -1 | 0 | N/A |
3/31/2023 | 5 | 1 | 2 | 3 | N/A |
12/31/2022 | 3 | 3 | 5 | 6 | N/A |
9/30/2022 | 3 | 3 | 5 | 6 | N/A |
6/30/2022 | 3 | 4 | 5 | 6 | N/A |
3/31/2022 | 3 | 0 | 1 | 2 | N/A |
12/31/2021 | 3 | -3 | -4 | -3 | N/A |
9/30/2021 | 3 | -3 | N/A | N/A | N/A |
6/30/2021 | 3 | -3 | N/A | N/A | N/A |
3/31/2021 | 2 | -2 | N/A | N/A | N/A |
12/31/2020 | 2 | -2 | -5 | -3 | N/A |
12/31/2019 | 1 | -2 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALSMA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALSMA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALSMA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALSMA's revenue (19.1% per year) is forecast to grow faster than the French market (5.7% per year).
High Growth Revenue: ALSMA's revenue (19.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALSMA's Return on Equity is forecast to be low in 3 years time (11.9%).